Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca(2+)/Calcineurin/p-NFATc3 Pathway

This study aimed to investigate the protective effect and molecular mechanism of spironolactone in isoproterenol-induced cardiomyocyte hypertrophy. In this study, primary cardiomyocytes were extracted from the heart of neonatal rats. After stable culture, they were processed with isoproterenol alone...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Zhang, Wenting, Na, Jingtao, Huo, Yanping, Wang, Yacheng, Liu, Ketong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702305/
https://www.ncbi.nlm.nih.gov/pubmed/34956570
http://dx.doi.org/10.1155/2021/3843830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702305/
https://www.ncbi.nlm.nih.gov/pubmed/34956570
http://dx.doi.org/10.1155/2021/3843830

Ejemplares similares